ArticleCancers2020

Sunitinib-Containing Carborane Pharmacophore with the Ability to Inhibit Tyrosine Kinases Receptors FLT3, KIT and PDGFR-β, Exhibits Powerful In Vivo Anti-Glioblastoma Activity.

Catalina Alamón et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.